Pinnacle Wealth Planning Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$633K Buy
17,222
+3,261
+23% +$155K 0.07% 176
2025
Q4
$710K Sell
13,961
-3,199
-19% -$164K 0.07% 145
2025
Q3
$952K Sell
17,160
-1,630
-9% -$95.4K 0.11% 104
2025
Q2
$1.3M Buy
18,790
+3,477
+23% +$237K 0.17% 77
2025
Q1
$1.06M Buy
15,313
+1,053
+7% +$87K 0.16% 82
2024
Q4
$1.23M Sell
14,260
-2,451
-15% -$265K 0.18% 65
2024
Q3
$1.99M Sell
16,711
-120
-0.7% -$16K 0.27% 50
2024
Q2
$2.4M Sell
16,831
-101
-0.6% -$13.4K 0.34% 45
2024
Q1
$2.17M Sell
16,932
-13
-0.1% -$1.55K 0.32% 51
2023
Q4
$1.75M Sell
16,945
-60
-0.4% -$5.93K 0.28% 55
2023
Q3
$1.55M Sell
17,005
-67
-0.4% -$5.9K 0.25% 54
2023
Q2
$1.38M Sell
17,072
-868
-5% -$70.9K 0.22% 67
2023
Q1
$1.43M Buy
17,940
+138
+0.8% +$9.79K 0.24% 62
2022
Q4
$1.2M Buy
17,802
+482
+3% +$28.3K 0.21% 71
2022
Q3
$863K Sell
17,320
-916
-5% -$49.1K 0.16% 87
2022
Q2
$1.02M Buy
18,236
+2,998
+20% +$166K 0.18% 85
2022
Q1
$846K Buy
15,238
+4,804
+46% +$247K 0.15% 105
2021
Q4
$584K Buy
10,434
+546
+6% +$29.6K 0.11% 137
2021
Q3
$475K Buy
9,888
+188
+2% +$9.09K 0.11% 148
2021
Q2
$406K Buy
9,700
+144
+2% +$5.58K 0.09% 174
2021
Q1
$322K Buy
9,556
+1,894
+25% +$67.5K 0.08% 208
2020
Q4
$268K Buy
7,662
+1,398
+22% +$48.3K 0.06% 220
2020
Q3
$217K Buy
6,264
+14
+0.2% +$467 0.07% 220
2020
Q2
$205K Sell
6,250
-554
-8% -$17.7K 0.07% 223
2020
Q1
$204K Buy
+6,804
New +$203K 0.1% 192

Other funds holding NVO

Pinnacle Wealth Planning Services's NVO Position: Q1 2026 in Review

Pinnacle Wealth Planning Services increased its Novo Nordisk (NVO) stake by 23% in Q1 2026, buying an estimated $155K and bringing the position to 17,222 shares worth $633K. The position accounts for 0.07% of the portfolio, ranked #176.

Pinnacle Wealth Planning Services first reported a position in NVO in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.4M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Pinnacle Wealth Planning Services held 17,222 shares of Novo Nordisk worth $633K as of Q1 2026.
  • Pinnacle Wealth Planning Services bought 3,261 Novo Nordisk shares in Q1 2026, an estimated $155K.
  • Novo Nordisk made up 0.07% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #176 holding.
  • Pinnacle Wealth Planning Services first reported a position in Novo Nordisk in Q1 2020 and has held it in 25 quarters since.
  • Pinnacle Wealth Planning Services's Novo Nordisk position peaked at $2.4M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.